---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-008796"
form_type: "8-K"
ticker: "SHPH"
cik: "0001757499"
company_name: "Shuttle Pharmaceuticals Holdings, Inc."
filed_at: "2024-03-05T23:59:59+00:00"
generated_at: "2026-06-05T03:55:17.928895+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Shuttle Pharma receives additional 180-day Nasdaq grace period through Aug 2024 for bid price compliance

## Summary
- Nasdaq granted additional 180-day grace period until Aug 26, 2024 to regain $1.00 minimum bid price compliance.
- Company submitted Plan of Compliance including potential reverse stock split if needed.
- Initial 180-day grace period ended Feb 27, 2024; company had not yet regained compliance.
- CEO Dr. Anatoly Dritschilo to present at Emerging Growth Conference on March 6, 2024.
- If compliance not met by Aug 26, 2024, Nasdaq will delist; appeal possible.

## SEC filing metadata
- accession: 0001493152-24-008796
- form_type: 8-K
- ticker: SHPH
- cik: 0001757499
- company_name: Shuttle Pharmaceuticals Holdings, Inc.
- filed_at: 2024-03-05T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757499/000149315224008796/0001493152-24-008796-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757499/000149315224008796/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-008796
- JSON: https://secwatch.observer/filing/0001493152-24-008796.json
- Plain text: https://secwatch.observer/filing/0001493152-24-008796.txt

## Key facts
- Listing & Compliance Notices
  Shuttle Pharmaceuticals Holdings, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: February 29, 2024, the Company received formal approval from Nasdaq granting it an additional 180 days, or until August 26, 2024 (the “Compliance Date”), to regain compliance with the Bid Price Requirement. If at any time before the Compliance Date the closing bid price for the Company’s common stock is at least $1.00 for a minimum of 10 consecutive business days, the Staff will provide the Company written confirmation that it has regained compliance with the Bid Price Requirement. If the Company does not regain compliance with the Bid Price Requirement by the Compliance Date, the Staff will p
  evidence_url: https://www.sec.gov/Archives/edgar/data/1757499/000149315224008796/0001493152-24-008796-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.